Page last updated: 2024-10-25

debrisoquin and Amentia

debrisoquin has been researched along with Amentia in 1 studies

Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hubble, JP1
Kurth, JH1
Glatt, SL1
Kurth, MC1
Schellenberg, GD1
Hassanein, RE1
Lieberman, A1
Koller, WC1

Other Studies

1 other study available for debrisoquin and Amentia

ArticleYear
Gene-toxin interaction as a putative risk factor for Parkinson's disease with dementia.
    Neuroepidemiology, 1998, Volume: 17, Issue:2

    Topics: Aged; Apolipoproteins; Case-Control Studies; Comorbidity; Debrisoquin; Dementia; Environmental Expos

1998